Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Small Cap

Vista Pharma Share Price

Q: What is the Market Capitalization of Vista Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Vista Pharmaceuticals Ltd. is approximately ₹ 45.1 Cr.

Q: What are the PE and PB ratios for Vista Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Vista Pharmaceuticals Ltd. is -5.9, and the Price-to-Book (PB) ratio is 1.1.

Q: What is the 52-Week High and Low for Vista Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Vista Pharmaceuticals Ltd. shares was ₹ 12.38, and the lowest price was ₹ 5.71.

Q: Who are the major shareholders of Vista Pharmaceuticals Ltd.?

Significant shareholdings in Vista Pharmaceuticals Ltd. typically include entities such as: Public Promoter Mutual Funds Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Vista Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Vista Pharmaceuticals Ltd. is often compared with other major players such as Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs and Corona Remedies for analysis and benchmarking.

Vista Pharmaceuticals Ltd.

₹7.35

0.02(0.27%)

Trade Now

10th Apr 2026 | 10:30 AM

NSE :

Open Free Demat Account

Vista Pharma Performance

Price Movement

N/A

₹6.91

₹7.55

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹7.55

Low₹6.91

Open at₹7.55

Prev Close₹7.33

Volumes1.22 K

Avg Price₹7.38

Lower Circuit₹5.87

Upper Circuit₹8.79

Historical Performance

3M High₹8.87

3M Low₹5.71

1 Yr High₹12.38

1 Yr Low₹5.71

3 Yr High₹19.70

3 Yr Low₹5.71

5 Yr High₹19.70

5 Yr Low₹5.71

Vista Pharma Fundamentals

Market Cap

Low in industry

45.10 Cr.

PE Ratio (TTM)

Negative PE TTM

-5.90

Dividend Yield

Net Profit TTM

151% decr over last year

-7.69

Net Profit Growth

151% decr over last year

-7.69

PEG Ratio

Below industry Median

ROE

8.2% incr over last year

-10.23

Operating Revenue TTM

8.63

Operating Revenue Growth

14% decr over last year

Book Value

Low in industry

1.10

MFI

MFI Overbought

71.21

RSI

RSI is mid-range

54.20

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

1.10

Vista Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	2.42	1.46	1.52	3.23	2.56
Operating Expense	5.42	4.90	2.63	4.14	4.07
Operating Profit	-3.01	-3.44	-1.11	-0.91	-1.52
Depreciation	0.19	0.20	0.18	0.18	0.19
Interest	0.18	0.18	0.19	0.21	0.22
Tax	-0.96	-1.03	-0.19	0.43	-0.48
Net Profit	-2.32	-2.59	-1.29	-1.50	-1.32

Vista Pharma Technicals

Vista Pharmaceuticals Ltd. EMA & SMA

₹7.35

0.26 (3.67%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹7

Day EMA10 ₹6.9

Day EMA12 ₹6.9

Day EMA20 ₹6.9

Day EMA26 ₹6.9

Day EMA50 ₹7.1

Day EMA100 ₹7.7

Day EMA200 ₹8.7

Vista Pharma Support and Resistance

Resistance

First Resistance₹7.71

Second Resistance₹8.09

Third Resistance₹8.59

Support

First Support₹6.83

Second Support₹6.33

Third Support₹5.95

Technical Indicators

Day RSI54.20

Day MFI71.21

Day ADX22.09

Day Commodity Channel Index82.40

William-50.99

Day MACD-

Day MACD Signal Line-0.07

Day ATR0.81

Day ROC125-23.41

Day ROC219.57

Vista Pharma Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	21.2	21.2	21.2	21.2	21.2	21.2
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	78.8	78.8	78.8	78.8	78.8	78.8

Vista Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	2.98 K	3.3 K	90.30%
Week	6.07 K	7.08 K	85.79%
1 Month	58.13 K	62.64 K	92.81%
6 Month	18.04 K	21.83 K	82.62%

Vista Pharma SWOT Analysis

Strengths14

Weakness9

Opportunity0

Threats0

Positive Breakout Second Resistance ( LTP > R2)

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Top Gainers

Volume Shockers

Vista Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Vista Pharma Stock Comparison

Financials	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.
Price (₹)	₹428.55	₹155.30	₹203	₹39.87	₹7.36	₹108.20
% Change	1.38%	4.97%	0.42%	2.00%	4.99%	2.08%
Revenue TTM (₹ Cr)	-	-	-	₹0.54	₹83.60	-
Net Profit TTM (₹ Cr)	-	-	-	₹-0.24	₹-34.95	-
PE TTM	-	15.10	56.30	-99.40	-1.70	14.00
1 Year Return	7.83			768.67	601	-17.19
ROCE	28.91	-	-	-	-5.63	-

Similar Stocks

APPL

Aptus Pharma Ltd.

₹ 362.00

+1.97%

AMANTA

Amanta Healthcare Ltd.

₹ 111.84

+5.48%

AHCL

Anlon Healthcare Ltd.

₹ 130.59

+7.38%

MEDISTEP

Medistep Healthcare Ltd.

₹ 20.00

-1.48%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 81.45

+5.78%

APL

Asston Pharmaceuticals Ltd.

₹ 87.29

+0.00%

INFLUX

Influx Healthtech Ltd.

₹ 235.00

+1.40%

TLL

Trident Lifeline Ltd.

₹ 247.85

-0.24%

DPL

Dipna Pharmachem Ltd.

₹ 9.20

+0.00%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.60

+0.00%

FABINO

Fabino Enterprises Ltd.

₹ 19.35

+0.00%

SIGACHI

Sigachi Industries Ltd.

₹ 21.73

+4.32%

WINDLAS

Windlas Biotech Ltd.

₹ 805.30

+0.76%

VINEETLAB

Vineet Laboratories Ltd.

₹ 32.35

-2.24%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 33.60

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 490.00

+1.80%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.54

+3.85%

ZIMLAB

Zim Laboratories Ltd.

₹ 72.70

+1.69%

BPLPHARMA

Bharat Parenterals Ltd.

₹ 1248.95

+4.87%

MEDICO

Medico Remedies Ltd.

₹ 38.56

+1.23%

SGRL

Shree Ganesh Remedies Ltd.

₹ 488.00

+2.89%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 161.50

+1.93%

LASA

Lasa Supergenerics Ltd.

₹ 7.78

+2.91%

ANG

ANG Lifesciences India Ltd.

₹ 24.25

+3.77%

SMRUTHIORG

Smruthi Organics Ltd.

₹ 111.00

+2.91%

FAQ's on VISTAPH

What is the Market Capitalization of Vista Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Vista Pharmaceuticals Ltd. is approximately ₹ 45.1 Cr.

What are the PE and PB ratios for Vista Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Vista Pharmaceuticals Ltd. is -5.9, and the Price-to-Book (PB) ratio is 1.1.

What is the 52-Week High and Low for Vista Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Vista Pharmaceuticals Ltd. shares was ₹ 12.38, and the lowest price was ₹ 5.71.

Who are the major shareholders of Vista Pharmaceuticals Ltd.?

Significant shareholdings in Vista Pharmaceuticals Ltd. typically include entities such as:

Public
Promoter
Mutual Funds
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Vista Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Vista Pharmaceuticals Ltd. is often compared with other major players such as Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs and Corona Remedies for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy